| (USD) | Apr 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -30.23M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ENGN returned -58.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -80.3% |
| 1 year | -58.8% |
| All-time high | $21.69 (Oct 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ENGN would be worth today ›No. enGene Therapeutics Inc. has not paid a dividend in the past 12 months.
enGene Therapeutics Inc. stock trades on NASDAQ under the ticker symbol ENGN.
enGene Therapeutics Inc. is part of the Healthcare sector.
enGene Therapeutics Inc. has a market cap of 119.24M USD, based on the latest quote.
enGene Therapeutics Inc. is expected to report earnings around Sep 14, 2026. That date is an estimate and has not been confirmed by the company.
